AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14568853 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume hospitals
Number of subjects: 3161
Study 14568853 — intervention group
Group type: COMPARATOR
Intervention: Low-volume hospitals
Number of subjects: 3161
Study 11871816 — intervention group
Group type: COMPARATOR
Intervention: Open hemorrhoidectomy
Number of subjects: 34
Study 11871816 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-closed hemorrhoidectomy
Number of subjects: 34
Study 10399998 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 2245
Study 7583806 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous infusion (SC) of 1000 mL of 5% glucose solution containing 4 g NaCl over 6 hours
Number of subjects: 6
Study 7583806 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion (IV) of 1000 mL of 5% glucose solution containing 4 g NaCl over 6 hours
Number of subjects: 6
Study 7583806 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SC and IV infusions
Number of subjects: 6
Study 2179286 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg od)
Number of subjects: 83
Study 2179286 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 mg od)
Number of subjects: 83
Study 7023743 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled clinical trial
Number of subjects: 0
Study 7023743 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal of patients due to ineligibility, lack of compliance, or poor data quality
Number of subjects: 0
Study 30944359 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced Index (BI)
Number of subjects: 0
Study 30944359 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Performance Index (GPI)
Number of subjects: 0
Study 28183303 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-stigma-targeted lecture
Number of subjects: 834
Study 28183303 — intervention group
Group type: COMPARATOR
Intervention: Non-targeted lecture
Number of subjects: 834
Study 25918756 — intervention group
Group type: EXPERIMENTAL
Intervention: Separator placement
Number of subjects: 100
Study 25918756 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial arch wire ligation (0.016 NiTi)
Number of subjects: 100
Study 25918756 — intervention group
Group type: EXPERIMENTAL
Intervention: T‐loop activation
Number of subjects: 100
Study 25918756 — intervention group
Group type: COMPARATOR
Intervention: Banding
Number of subjects: 100
Study 25918756 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermaxillary elastics
Number of subjects: 100
Study 23817160 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy
Number of subjects: 8
Study 23817160 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoanalysis
Number of subjects: 8
Study 23817160 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 8
Study 23817160 — intervention group
Group type: COMPARATOR
Intervention: Clinical management
Number of subjects: 8
Study 21112682 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet peer support via a listserv
Number of subjects: 300
Study 21112682 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet peer support via a bulletin board
Number of subjects: 300
Study 21112682 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 300
Study 19579197 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin polymer instillation (Bioglue Cryolife, Inc.) during surgery
Number of subjects: 68
Study 19579197 — intervention group
Group type: COMPARATOR
Intervention: Non-polymer treatment during surgery
Number of subjects: 68
Study 19579197 — intervention group
Group type: COMPARATOR
Intervention: Non-polymer treatment
Number of subjects: 68
Study 19579197 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer treatment
Number of subjects: 68
Study 17446407 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric resistance training of the plantar flexor muscles (12 sessions over 4 weeks)
Number of subjects: 20
Study 17446407 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 15262187 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg per day)
Number of subjects: 13
Study 15262187 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (1 microM in vitro)
Number of subjects: 13
Study 15262187 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenyl transferase inhibitors (in vitro)
Number of subjects: 13
Study 11254825 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intravenous pamidronate every 3 months + 1 g calcium daily
Number of subjects: 28
Study 11254825 — intervention group
Group type: COMPARATOR
Intervention: 1 g calcium daily
Number of subjects: 28
Study 9567053 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy for the prevention of recurrence of unipolar affective disorders
Number of subjects: 0
Study 9567053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8313786 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin intrahepatic arterial infusion (24 mg/m2/day, bolus) plus systemic intravenous 5-fluorouracil (250, 375, or 500 mg/m2/day)
Number of subjects: 109
Study 8313786 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin continuous infusion (24 mg/m2/day) plus systemic intravenous 5-fluorouracil (250, 375, or 500 mg/m2/day)
Number of subjects: 109
Study 3049338 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg/day
Number of subjects: 343
Study 3049338 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 100 mg/day
Number of subjects: 343
Study 3049338 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 200 mg/day
Number of subjects: 343
Study 3049338 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (varied doses)
Number of subjects: 343
Study 28971569 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush alone
Number of subjects: 60
Study 28971569 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush plus dental floss
Number of subjects: 60
Study 28971569 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush plus interdental brushes
Number of subjects: 60
Study 28971569 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush plus rubber interdental picks
Number of subjects: 60
Study 28971569 — intervention group
Group type: COMPARATOR
Intervention: Control group (manual toothbrush only)
Number of subjects: 60
Study 27470295 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat grafting
Number of subjects: 18
Study 27470295 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study 24957823 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-824 with efavirenz
Number of subjects: 52
Study 24957823 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-824 with lopinavir-ritonavir
Number of subjects: 52
Study 24957823 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-824 with rifampin
Number of subjects: 52
Study 24957823 — intervention group
Group type: COMPARATOR
Intervention: PA-824 alone
Number of subjects: 52
Study 21853390 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS) fixation (TISSEEL)
Number of subjects: 89
Study 21853390 — intervention group
Group type: COMPARATOR
Intervention: Staple mesh fixation (ST) (EMS Stapler)
Number of subjects: 89
Study 21853390 — intervention group
Group type: COMPARATOR
Intervention: Both FS and ST groups
Number of subjects: 89
Study 19834809 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed virtual chromoendoscopy (CVC) mode colonoscopy
Number of subjects: 128
Study 19834809 — intervention group
Group type: COMPARATOR
Intervention: Conventional white-light colonoscopy
Number of subjects: 128
Study 18296027 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of methylprednisolone injected into the masseter muscle
Number of subjects: 35
Study 18296027 — intervention group
Group type: COMPARATOR
Intervention: No intramuscular corticoid (control group)
Number of subjects: 35
Study 15702708 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Doppler flowmetry (LDF)
Number of subjects: 69
Study 15702708 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 15352598 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic evacuation of the hematoma
Number of subjects: 242
Study 15352598 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 242
Study 11113722 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan titrated to 160 mg b.i.d.
Number of subjects: 5010
Study 11113722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5010
Study 9196156 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine 1,000 mg/m2 weekly x 7 followed by 1 week of rest, then weekly x 3 every 4 weeks thereafter
Number of subjects: 126
Study 9196156 — intervention group
Group type: COMPARATOR
Intervention: fluorouracil (5‐FU) 600 mg/m2 once weekly
Number of subjects: 126
Study 9196156 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine
Number of subjects: 126
Study 9196156 — intervention group
Group type: COMPARATOR
Intervention: 5‐FU
Number of subjects: 126
Study 7505354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil (25 mg)
Number of subjects: 10
Study 7505354 — intervention group
Group type: COMPARATOR
Intervention: Quinidine (330 mg)
Number of subjects: 10
Study 7505354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3987800 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. infusions of adriamycin (short: 3.00 min)
Number of subjects: 21
Study 3987800 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. infusions of adriamycin (prolonged: 45 min‐16 h)
Number of subjects: 21
Study 3987800 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. infusions of adriamycin
Number of subjects: 21
Study 3277903 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural progesterone, 100 mg 2 times daily
Number of subjects: 33
Study 3277903 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen, 10 mg 2 times daily
Number of subjects: 33
Study 3277903 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 33
Study 31799996 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine gel, 0.33%
Number of subjects: 20
Study 31799996 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 20
Study 31238715 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal pre-pregnancy body mass index increase
Number of subjects: 587
Study 31238715 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal pre-pregnancy body mass index
Number of subjects: 587
Study 31238715 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal pre-pregnancy body mass index
Number of subjects: 587
Study 28639366 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time video feedback of their own back during massage treatment
Number of subjects: 20
Study 28639366 — intervention group
Group type: COMPARATOR
Intervention: Watching a neutral object (control)
Number of subjects: 20
Study 28639366 — intervention group
Group type: COMPARATOR
Intervention: Video of another person of the same sex being massaged (control)
Number of subjects: 20
Study 28639366 — intervention group
Group type: COMPARATOR
Intervention: Picture of the own back (control)
Number of subjects: 20
Study 28639366 — intervention group
Group type: COMPARATOR
Intervention: Keeping one's eyes closed (control)
Number of subjects: 20
Study 25800891 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorinostat 300 mg twice daily on specified days of a 21-day cycle
Number of subjects: 661
Study 25800891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 661
Study 25800891 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorinostat
Number of subjects: 661
Study 23467941 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 100
Study 23467941 — intervention group
Group type: COMPARATOR
Intervention: Atracurium
Number of subjects: 100
Study 22282574 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention on compliance with road safety signs
Number of subjects: 200
Study 22282574 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study 20129545 — intervention group
Group type: EXPERIMENTAL
Intervention: XIENCE V everolimus-eluting stent (EES)
Number of subjects: 300
Study 20129545 — intervention group
Group type: COMPARATOR
Intervention: TAXUS paclitaxel-eluting stent (PES)
Number of subjects: 300
Study 17075501 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrilarm capsules, twice a day for 6 months
Number of subjects: 71
Study 17075501 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules, twice a day for 6 months
Number of subjects: 71
Study 11894595 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular stent-graft implantation
Number of subjects: 26
Study 10414072 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified URS LAR VII with LMA
Number of subjects: 14
Study 10414072 — intervention group
Group type: COMPARATOR
Intervention: AMBU bag
Number of subjects: 14
Study 7750023 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release formulation B
Number of subjects: 12
Study 7750023 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release formulation C
Number of subjects: 12
Study 7750023 — intervention group
Group type: COMPARATOR
Intervention: Nonsustained-release reference preparation A
Number of subjects: 12
Study 2105675 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 20
Study 2105675 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol + Sodium cromoglycate
Number of subjects: 20
Study 2105675 — intervention group
Group type: COMPARATOR
Intervention: Sodium cromoglycate
Number of subjects: 20
Study 6107768 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV‐maltose (5% solution in 10% maltose)
Number of subjects: 29
Study 6107768 — intervention group
Group type: COMPARATOR
Intervention: IGIV (maltose-free immune globulin)
Number of subjects: 29
Study 6107768 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV‐maltose
Number of subjects: 29
Study 29885661 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-to-event (TTE) display
Number of subjects: 353
Study 29885661 — intervention group
Group type: EXPERIMENTAL
Intervention: Emoticons
Number of subjects: 353
Study 29885661 — intervention group
Group type: EXPERIMENTAL
Intervention: Bar chart
Number of subjects: 353
Study 27491607 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramyocardial CD34(+) cell administration
Number of subjects: 112
Study 27491607 — intervention group
Group type: COMPARATOR
Intervention: Open-label standard of care
Number of subjects: 112
Study 27491607 — intervention group
Group type: COMPARATOR
Intervention: Active control (IM placebo injections)
Number of subjects: 112
Study 26537273 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Citrate
Number of subjects: 0
Study 26537273 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Carbonate
Number of subjects: 0
Study 23807323 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m2)
Number of subjects: 85
Study 23807323 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (60 mg/m2)
Number of subjects: 85
Study 20069285 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated feedback using Lissajous plots
Number of subjects: 0
Study 20069285 — intervention group
Group type: COMPARATOR
Intervention: Control condition without integrated feedback
Number of subjects: 0
Study 18361983 — intervention group
Group type: EXPERIMENTAL
Intervention: AF‐1 (UY) blue‐light‐filtering intraocular lens
Number of subjects: 0
Study 18361983 — intervention group
Group type: COMPARATOR
Intervention: AF‐1 (UV) intraocular lens
Number of subjects: 0
Study 17149987 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (PLY; n = 7) - 3 x 30 minutes sessions per week for 9 weeks
Number of subjects: 15
Study 17149987 — intervention group
Group type: COMPARATOR
Intervention: Control (CON; n = 8)
Number of subjects: 15
Study 15259924 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS therapy for 20 minutes
Number of subjects: 20
Study 15259924 — intervention group
Group type: COMPARATOR
Intervention: No TENS therapy (control group)
Number of subjects: 20
Study 10904661 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics for three days
Number of subjects: 0
Study 10904661 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics without examination of the urine
Number of subjects: 0
Study 10904661 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment by telephone for women with earlier episodes of UTI
Number of subjects: 0
Study 10904661 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0
Study 10904661 — intervention group
Group type: COMPARATOR
Intervention: Negative dipstick test
Number of subjects: 0
Study 10904661 — intervention group
Group type: COMPARATOR
Intervention: Dysuria or frequency
Number of subjects: 0
Study 9273209 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous Epo (2000 U, twice weekly)
Number of subjects: 19
Study 9273209 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Epo (156 +/- 57 U/kg/week to 205 +/- 105 U/kg/week, thrice weekly)
Number of subjects: 19
Study 2059819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 10
Study 6354441 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential administration of ifosfamide (with mesna), methotrexate (or 5-FU), and vinblastine (protocol I)
Number of subjects: 29
Study 6354441 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined administration of adriamycin and vincristine (protocol II)
Number of subjects: 29
Study 31909561 — intervention group
Group type: EXPERIMENTAL
Intervention: FE NO measurements with initial FE NO <50 ppb
Number of subjects: 1112
Study 31909561 — intervention group
Group type: EXPERIMENTAL
Intervention: FE NO measurements with initial FE NO ≥50 ppb
Number of subjects: 1112
Study 31909561 — intervention group
Group type: EXPERIMENTAL
Intervention: FE NO measurements over a 3-month period
Number of subjects: 1112
Study 30418217 — intervention group
Group type: COMPARATOR
Intervention: Balanced hydroxyethyl starch solution (colloid)
Number of subjects: 160
Study 30418217 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloid solution (crystalloid)
Number of subjects: 160
Study 30618445 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dose sulphadoxine-pyrimethamine (SP)
Number of subjects: 210
Study 30618445 — intervention group
Group type: COMPARATOR
Intervention: Two-dose sulphadoxine-pyrimethamine (SP)
Number of subjects: 210
Study 26518245 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 140
Study 26518245 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 140
Study 25268398 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-injection technique (group M)
Number of subjects: 90
Study 25268398 — intervention group
Group type: COMPARATOR
Intervention: Single-injection technique (group S)
Number of subjects: 90
Study 21669958 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell phone intervention (CPI)
Number of subjects: 474
Study 21669958 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 474
Study 20534327 — intervention group
Group type: EXPERIMENTAL
Intervention: Masticated rice with varying particle sizes
Number of subjects: 15
Study 20534327 — intervention group
Group type: EXPERIMENTAL
Intervention: Masticated rice with particles smaller than 500 microm
Number of subjects: 15
Study 20534327 — intervention group
Group type: EXPERIMENTAL
Intervention: Masticated rice with particles greater than 2000 microm
Number of subjects: 15
Study 20534327 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro digestion of rice
Number of subjects: 15
Study 20534327 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall habitual mastication
Number of subjects: 15
Study 18171953 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation combined with percutaneous pin fixation
Number of subjects: 137
Study 18171953 — intervention group
Group type: COMPARATOR
Intervention: Plate fixation
Number of subjects: 137
Study 15763607 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumiracoxib 100 mg QD
Number of subjects: 1551
Study 15763607 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumiracoxib 100 mg QD with loading dose
Number of subjects: 1551
Study 15763607 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg QD
Number of subjects: 1551
Study 15763607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1551
Study 12686794 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport 500 units
Number of subjects: 234
Study 12686794 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport 1,000 units
Number of subjects: 234
Study 12686794 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport 1,500 units
Number of subjects: 234
Study 12686794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 9892252 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine, 50 mg/d
Number of subjects: 47
Study 9892252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 9160649 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 20
Study 9160649 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 20
Study 1425861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified oral nutrition with nutrition education, daily dietician visits, and food intake records.
Number of subjects: 29
Study 1425861 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum nutritional intake during the whole tumour therapy.
Number of subjects: 29
Study 1425861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified oral nutrition.
Number of subjects: 29
Study 1425861 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum nutritional intake.
Number of subjects: 29
Study 6721407 — intervention group
Group type: EXPERIMENTAL
Intervention: Small (2.5 mm) Redivac drain
Number of subjects: 50
Study 6721407 — intervention group
Group type: COMPARATOR
Intervention: Large (6 mm) Redivac drain
Number of subjects: 50